In an article by BioSpace, Philadelphia is showcased as a major life sciences hub, particularly in cell and gene therapy, with over 60 companies and institutions contributing to industry advancements. Increased investment in lab space and infrastructure in recent years has fueled biotech growth, with Philadelphia ranking as a top life sciences market and boasting a strong talent pipeline from local universities.
Dora Mitchell, senior vice president of operations and chief of staff at Interius Biotherapeutics, and Nick Siciliano, CEO, co-founder and director of ViTToria Biotherapeutics, spoke to Biospace about Philadelphia’s strong talent pool, proximity to resources, and real estate growth. Interius and ViTToria are Penn spinouts co-founded by Saar Gill, MD, PhD, Associate Professor of Medicine (Hematology-Oncology) and Marco Ruella, MD, Assistant Professor of Medicine in the Division of Hematology and Oncology, respectively. Read the full article here.